ArticleOncotarget2016

Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling.

Benjamin Y Owusu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.